-
1
-
-
66049083487
-
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
-
Basu S, Harfouche R, Soni S et al. (2009) Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy. Proc Natl Acad Sci USA 106:7957-61
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 7957-7961
-
-
Basu, S.1
Harfouche, R.2
Soni, S.3
-
2
-
-
78149467932
-
Targeted nanoparticles deliver siRNA to melanoma
-
Chen Y, Bathula SR, Yang Q et al. (2010) Targeted nanoparticles deliver siRNA to melanoma. J Invest Dermatol 130:2790-8
-
(2010)
J Invest Dermatol
, vol.130
, pp. 2790-2798
-
-
Chen, Y.1
Bathula, S.R.2
Yang, Q.3
-
3
-
-
65649147543
-
Braf(V600E) cooperates with Pten loss to induce metastatic melanoma
-
Dankort D, Curley D P, Cartlidge RA et al. (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41:544-52
-
(2009)
Nat Genet
, vol.41
, pp. 544-552
-
-
Dankort, D.1
Curley, D.P.2
Cartlidge, R.A.3
-
4
-
-
67651246671
-
Phase i study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer
-
(Abstract 9000)
-
Flaherty K, Puzanov I, Sosman J et al. (2009) Phase I study of PLX4032: proof of concept for V600E BRAF mutation as a therapeutic target in human cancer. J Clin Oncol 27: 15S (Abstract 9000)
-
(2009)
J Clin Oncol
, vol.27
-
-
Flaherty, K.1
Puzanov, I.2
Sosman, J.3
-
5
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
Hodi FS, O'Day SJ, McDermott DF et al. (2010) Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363:711-23
-
(2010)
N Engl J Med
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
-
6
-
-
48849105341
-
Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells
-
Mannava S, GrachtchoukV, Wheeler LJ et al. (2008) Direct role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cells. Cell Cycle 7:2392-400
-
(2008)
Cell Cycle
, vol.7
, pp. 2392-2400
-
-
Mannava, S.1
Grachtchouk, V.2
Wheeler, L.J.3
-
7
-
-
0031973401
-
Expression of c-Myc oncoprotein represents a new prognostic marker in cutaneous melanoma
-
Ross DA, Wilson GD (1998) Expression of c-Myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Br J Surg 85:46-51
-
(1998)
Br J Surg
, vol.85
, pp. 46-51
-
-
Ross, D.A.1
Wilson, G.D.2
-
8
-
-
54849373400
-
Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development
-
Tran MA, Gowda R, Sharma A et al. (2008) Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res 68:7638-49
-
(2008)
Cancer Res
, vol.68
, pp. 7638-7649
-
-
Tran, M.A.1
Gowda, R.2
Sharma, A.3
-
9
-
-
55349098455
-
Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA
-
Villares GJ, Zigler M, Wang H et al. (2008) Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. Cancer Res 68:9078-86
-
(2008)
Cancer Res
, vol.68
, pp. 9078-9086
-
-
Villares, G.J.1
Zigler, M.2
Wang, H.3
-
10
-
-
70449629655
-
WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth
-
Zamora-Avila DE, Zapata-Benavides P, Franco-Molina MA et al. (2009) WT1 gene silencing by aerosol delivery of PEI-RNAi complexes inhibits B16-F10 lung metastases growth. Cancer Gene Ther 16:892-9
-
(2009)
Cancer Gene Ther
, vol.16
, pp. 892-899
-
-
Zamora-Avila, D.E.1
Zapata-Benavides, P.2
Franco-Molina, M.A.3
-
11
-
-
56149126490
-
C-Myc overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
-
Zhuang D, Mannava S, Grachtchouk V et al. (2008) C-Myc overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells. Oncogene 27:6623-34
-
(2008)
Oncogene
, vol.27
, pp. 6623-6634
-
-
Zhuang, D.1
Mannava, S.2
Grachtchouk, V.3
|